Article
AcornHRD: an HRD algorithm highly associated with anthracycline-based neoadjuvant chemotherapy in breast cancer in China.
European journal of medical research - 16 Jul 2024
Pan Jia-Ni, Li Pu-Chun, Wang Meng, Li Ming-Wei, Ding Xiao-Wen, Zhou Tao, Wang Hui-Na, Wang Yun-Kai, Chen Li-Bin, Wang Rong, Ye Wei-Wu, Wu Wei-Zhu, Lou Feng, Wang Xiao-Jia, Cao Wen-Ming
Abstract excerpt
PURPOSE: Our study aimed to develop and validate a homologous recombination deficiency (HRD) scoring algorithm in the Chinese breast cancer population. METHODS AND MATERIALS: Ninety-six in-house breast cancer (BC) samples and 6 HRD-positive standard cells were analyzed by whole-genome sequencing (WGS). Besides, 122 BCs from the TCGA database were down-sampled to ~ 1X WGS. We constructed an algorithm named...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
